Portland Psychotherapy is a clinic, research and training centre with a unique business model that funds scientific research. This results in a team of therapists who are exceptionally well-trained and knowledgeable about their areas of speciality.
Portland Psychotherapy Clinic
Co-Founder and current Director, Jason Luoma, and his colleagues at MAPS are working on a clinical trial investigating the use of MDMA in the treatment of social anxiety disorder.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Related Course(s)
Intermediate Workshop II on Ketamine-Assisted PsychotherapyThe Intermediate Workshop II on Ketamine-Assisted Psychotherapy course is designed for mental health professionals who have completed the Introduction to Ketamine-Assisted Psychotherapy course and the Intermediate Workshop I on Ketamine-Assisted Psychotherapy course.
Intermediate Workshop IV on Ketamine-Assisted Psychotherapy
This fourth intermediate workshop is designed for healthcare professionals who have completed the Introduction to Ketamine-Assisted Psychotherapy (KAP) course and are interested in learning more about the use of ketamine in the treatment of mental health conditions.